First Citizens Bank & Trust Co. acquired a new position in shares of Cognex Corporation (NASDAQ:CGNX - Free Report) in the second quarter, according to the company in its most recent disclosure with the SEC. The firm acquired 20,015 shares of the scientific and technical instruments company's stock, valued at approximately $635,000.
A number of other hedge funds have also recently made changes to their positions in CGNX. GAMMA Investing LLC boosted its position in shares of Cognex by 155.3% during the 1st quarter. GAMMA Investing LLC now owns 1,062 shares of the scientific and technical instruments company's stock worth $32,000 after purchasing an additional 646 shares during the period. Janney Montgomery Scott LLC boosted its position in shares of Cognex by 26.9% during the 1st quarter. Janney Montgomery Scott LLC now owns 32,316 shares of the scientific and technical instruments company's stock worth $964,000 after purchasing an additional 6,847 shares during the period. Perigon Wealth Management LLC boosted its position in shares of Cognex by 7.6% during the 1st quarter. Perigon Wealth Management LLC now owns 12,032 shares of the scientific and technical instruments company's stock worth $359,000 after purchasing an additional 847 shares during the period. Confluence Wealth Services Inc. boosted its stake in shares of Cognex by 19.5% in the first quarter. Confluence Wealth Services Inc. now owns 32,754 shares of the scientific and technical instruments company's stock valued at $977,000 after purchasing an additional 5,347 shares during the period. Finally, Vontobel Holding Ltd. boosted its stake in shares of Cognex by 2.9% in the first quarter. Vontobel Holding Ltd. now owns 44,167 shares of the scientific and technical instruments company's stock valued at $1,318,000 after purchasing an additional 1,262 shares during the period. Hedge funds and other institutional investors own 88.12% of the company's stock.
Analyst Ratings Changes
Several research analysts have recently commented on CGNX shares. Truist Financial set a $45.00 price objective on shares of Cognex and gave the company a "hold" rating in a research note on Wednesday, October 8th. The Goldman Sachs Group raised their price objective on shares of Cognex from $36.00 to $40.00 and gave the company a "sell" rating in a research note on Tuesday, September 16th. Weiss Ratings reissued a "hold (c)" rating on shares of Cognex in a research note on Friday. KeyCorp raised shares of Cognex from a "sector weight" rating to an "overweight" rating and set a $50.00 price objective for the company in a research note on Friday, August 1st. Finally, Melius raised shares of Cognex from a "hold" rating to a "buy" rating and set a $60.00 price objective for the company in a research note on Thursday, July 10th. Two equities research analysts have rated the stock with a Strong Buy rating, seven have given a Buy rating, eight have assigned a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, the company has an average rating of "Moderate Buy" and an average target price of $44.93.
Get Our Latest Stock Report on Cognex
Cognex Stock Up 0.6%
Shares of Cognex stock opened at $48.35 on Friday. Cognex Corporation has a 52-week low of $22.67 and a 52-week high of $49.76. The company has a 50 day moving average of $45.12 and a 200 day moving average of $36.26. The company has a market capitalization of $8.12 billion, a P/E ratio of 68.10 and a beta of 1.50.
Cognex (NASDAQ:CGNX - Get Free Report) last issued its quarterly earnings results on Wednesday, July 30th. The scientific and technical instruments company reported $0.25 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.23 by $0.02. Cognex had a net margin of 13.13% and a return on equity of 6.65%. The company had revenue of $249.09 million during the quarter, compared to the consensus estimate of $246.70 million. During the same quarter in the previous year, the firm earned $0.23 earnings per share. The firm's quarterly revenue was up 4.2% on a year-over-year basis. Cognex has set its Q3 2025 guidance at 0.240-0.290 EPS. As a group, research analysts anticipate that Cognex Corporation will post 0.61 earnings per share for the current fiscal year.
Cognex Announces Dividend
The business also recently disclosed a quarterly dividend, which was paid on Thursday, August 28th. Stockholders of record on Thursday, August 14th were given a dividend of $0.08 per share. This represents a $0.32 annualized dividend and a dividend yield of 0.7%. The ex-dividend date was Thursday, August 14th. Cognex's payout ratio is currently 45.07%.
Insider Activity at Cognex
In other news, Director Robert Willett sold 6,704 shares of the business's stock in a transaction that occurred on Tuesday, October 21st. The shares were sold at an average price of $49.51, for a total transaction of $331,915.04. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, EVP Sheila Marie Dipalma sold 2,000 shares of the business's stock in a transaction that occurred on Monday, September 8th. The stock was sold at an average price of $45.03, for a total transaction of $90,060.00. Following the sale, the executive vice president owned 6,582 shares of the company's stock, valued at $296,387.46. This represents a 23.30% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 10,706 shares of company stock valued at $512,065 in the last 90 days. Insiders own 1.60% of the company's stock.
Cognex Profile
(
Free Report)
Cognex Corporation provides machine vision products that capture and analyze visual information to automate manufacturing and distribution tasks worldwide. Its machine vision products are used to automate the manufacturing and tracking of discrete items, including mobile phones, electric vehicle batteries, and e-commerce packages by locating, identifying, inspecting, and measuring them during the manufacturing or distribution process.
Featured Stories
Want to see what other hedge funds are holding CGNX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cognex Corporation (NASDAQ:CGNX - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Cognex, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cognex wasn't on the list.
While Cognex currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.